As a global leader in biopharmaceutical contract manufacturing with more than 35 years of biotechnology experience and a global network of biopharma manufacturing facilities, our track record speaks for itself. Find out more about partnering with us.

Citizen Petition

Boehringer Ingelheim has filed a Citizen Petition asking the FDA to correct its interpretation of the term “strength” as used in the Biologics Price Competition and Innovation Act (“BPCIA”).